We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Clinical laboratory evaluation of hemostasis
- Key steps in clinical laboratory evaluation of hemostasis
- The pre-analytical phase of coagulation testing
- Pre-analytical variables
- Clinical laboratory evaluation of hemostasis: interferences
- Primary hemostasis investigation: diagnostic tests
- Primary hemostasis investigation: specialized tests
- Diverse clinical laboratory coagulation testing
- Clinical laboratory coagulation testing
- Clinical laboratory evaluation of thrombophilia
- Clinical laboratory coagulation testing: fibrinolysis investigation
- Evaluation of anticoagulant monitoring
- Post-analytical phase in coagulation testing
- Financial disclosures
Topics Covered
- Blood test
- Sampling issues
- Blood sample management
- Errors in laboratory analysis caused by blood clotting
- Sample processing time
- Factors affecting blood sample analysis
- Hemostasis assays
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Salvagno, G.L. (2026, April 30). Laboratory assessment of coagulation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 30, 2026, from https://doi.org/10.69645/GPDR1859.Export Citation (RIS)
Publication History
- Published on April 30, 2026
Financial Disclosures
- There are no commercial relationships to disclose.
Other Talks in the Series: Clinical Biochemistry
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, everybody. My name
is Gian Luca Salvagno.
I am a full professor of
clinical biochemistry at
the University of Verona.
My training, I am a medical
doctor with a specialization in
clinical chemistry and a
PhD in laboratory medicine.
We discuss about the laboratory
assessment of coagulation.
0:27
In Slide 2, we describe today
the clinical laboratory
evaluation of hemostasis.
In hemostasis, it's
really important to
remember that we have
several aspects.
First of all, we have
endothelial cells,
platelets, and
coagulation factors.
We have endothelial
cells because
endothelial cells
produce a lot of
important proteins
and other molecules
that are really important
to start coagulation.
Endothelial cells also inside,
we have some kind
of organelle that
we have von Willebrand
factor inside.
Also, endothelial cells are
a source of tissue factors.
Tissue factors are really
important to start coagulation,
and are the most important part
to evaluate the hemostasis.
Platelets, instead, we have
this kind of little particle.
Their name is thrombocytes
or platelets.
They are not cells.
They're derived from
cells in the bone marrow.
Their name is megakaryocytes.
Platelets are really
important because they are
the key factor to start
hemostasis in the patient.
Platelets are important because
they are a source
of phospholipids.
When we have the
starting situation
of coagulation factors,
platelets produce because
platelets inside have
a lot of organelles that
have some kind of
coagulation factor.
But moreover, they have
some kind of agonist,
for example, ADP and calcium.
What is really interesting
is that calcium in humans
has two names, calcium,
but also in hemostasis is known
as coagulation factor IV.
Platelets are important
because they are the surface
where the coagulation
factors start to
work to produce fibrin finally.
Platelets also have
a lot of receptors.
We have a lot of receptors
on the platelets,
for example, receptors
for thrombin,
receptor for ADP, but also,
platelets have receptors
for fibrinogen,
receptors for von
Willebrand factor.
Platelets are the key
components to start
the formation of
hemostasis and thrombosis.
What is important to remember
is that the platelets
are, in the whole
blood we have, around
from 120000 to 400000
platelets per microliter.
When we have a low
count of platelets,
we have a situation, the
name is thrombocytopenia.
On the other hand, when we
have too much platelets,
the name is thrombocythemia.
Coagulation factor is
absolutely a key component,
because, in the whole blood,
we have 13 different
kinds of factors.